EUVIMEDEUVIMED entdecken
Crossref

G6PD+CSV+ circulating tumor cells associated with portal vein tumor thrombus formation via EMT-ferroptosis crosstalk: a dual biomarker for therapeutic efficacy and prognosis prediction in hepatocellular carcinoma

Lujun Chen, Heming Li, Qiuhua Luo, Haitao Zhou, Haoran Song, Xiaofang Liu, Mingfang Zhao, Tao Han, Kai Li

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2025.218205 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Lujun Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Gastrointestinal Onco-Pathology, Cancer Institute and General Surgery Institute, The First Hospital of China Medical University, Shenya…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Liver Neoplasms, Portal Vein. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Shenyang Municipal Bureau of Science and Technology, Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Portal vein tumor thrombus (PVTT) is a major contributor to recurrence, metastasis, and poor prognosis in hepatocellular carcinoma (HCC). Effective early detection and therapeutic strategies for PVTT are lacking. In our ongoing investigation, we identified cell surface vimentin-positive (CSV+) CTCs as a key subpopulation enriched in HCC patients with PVTT, whereas conventional EpCAM+ CTCs exhibited limited clinical relevance. Integrated multi-omics analyses further revealed that tumor cells within the primary lesion exhibiting both epithelial-mesenchymal transition (EMT) and ferroptosis-associated signatures are more likely to intravasate and contribute to PVTT formation. Notably, G6PD was identified as a ferroptosis-related marker specifically enriched in this EMT-like tumor cell subset, suggesting its functional involvement in PVTT pathogenesis. Clinically, elevated levels of G6PD+CSV+ CTCs were associated with poor responses to targeted immunotherapy. Importantly, the identification of CSV also provides a rationale for developing CSV-guided delivery systems, enabling targeted silencing of PVTT-associated molecular drivers such as G6PD. Collectively, our findings highlight G6PD+CSV+ CTCs as a dual-function biomarker for both PVTT risk stratification and treatment response monitoring, offering a novel strategy for the precision management of advanced HCC with PVTT involvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularNeoplastic Cells, CirculatingLiver NeoplasmsPortal VeinBiomarkers, TumorFerroptosisVimentinVenous ThrombosisHumansEpithelial-Mesenchymal TransitionPrognosisMaleFemaleAnimals

Stichwörter der Autor:innen

Circulating tumor cellsEpithelial-mesenchymal transitionFerroptosisHepatocellular carcinomaPortal vein tumor thrombus

Substanzen

Biomarkers, TumorVimentinVIM protein, human

Autor:innen und Institutionen

  • Laboratory of Gastrointestinal Onco-Pathology, Cancer Institute and General Surgery Institute, The First Hospital of China Medical University, Shenyang, 110001, China.
  • Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Department of Pharmacy, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, China.
  • Department of Colorectal Surgery, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Med…
  • Department of Anus and Intestine Surgery, the First Affiliated Hospital of China Medical University, 155# North Nanjing Street, Heping District, Shenyang City, 110001, Liaoning Province, China. Electronic address: xfliu…
  • Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China. Electronic address: zhaomf618@126.com.

Förderung

  • Shenyang Municipal Bureau of Science and Technology
  • Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Chen, L., Li, H., Luo, Q., Zhou, H., Song, H., Liu, X., Zhao, M., Han, T., & Li, K. (2026). G6PD+CSV+ circulating tumor cells associated with portal vein tumor thrombus formation via EMT-ferroptosis crosstalk: a dual biomarker for therapeutic efficacy and prognosis prediction in hepatocellular carcinoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.218205

Vancouver

Chen L, Li H, Luo Q, Zhou H, Song H, Liu X, et al. G6PD+CSV+ circulating tumor cells associated with portal vein tumor thrombus formation via EMT-ferroptosis crosstalk: a dual biomarker for therapeutic efficacy and prognosis prediction in hepatocellular carcinoma. Cancer Letters. 2026. doi:10.1016/j.canlet.2025.218205

BibTeX
@article{Chen2026,
  author = {Chen, Lujun and Li, Heming and Luo, Qiuhua and Zhou, Haitao and Song, Haoran and Liu, Xiaofang and Zhao, Mingfang and Han, Tao and Li, Kai},
  title = {G6PD+CSV+ circulating tumor cells associated with portal vein tumor thrombus formation via EMT-ferroptosis crosstalk: a dual biomarker for therapeutic efficacy and prognosis prediction in hepatocellular carcinoma},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2025.218205}
}
Kostenlos starten →